Patient blood management equals patient safety

Best Practice and Research: Clinical Anaesthesiology

Volumn 30, Issue 2, 2016, Pages 159-169

  Zacharowski, Kai ^a   Spahn, Donat R ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

anemia; hospital outcome; patient safety; red blood cell transfusion

Indexed keywords

ANEMIA; BLOOD; BLOOD TRANSFUSION; DISEASE MANAGEMENT; ERYTHROCYTE TRANSFUSION; HUMAN; PATIENT SAFETY;

ANEMIA; BLOOD TRANSFUSION; DISEASE MANAGEMENT; ERYTHROCYTE TRANSFUSION; HUMANS; PATIENT SAFETY;

EID: 84969963516     PISSN: 15216896     EISSN: 1532169X     Source Type: Journal    
DOI: 10.1016/j.bpa.2016.04.008     Document Type: Review

References (80)

1. [1] Shander, A., Van Aken, H., Colomina, M.J., et al. Patient blood management in Europe. Br J Anaesth 109 (2012), 55–68.
2. Goodnough, L.T., Shander, A., Patient blood management. Anesthesiology 116 (2012), 1367–1376.
3. Fischer, D.P., Zacharowski, K., Müller, M.M., et al. Patient blood management implementation strategies and their effect on Physicians’ risk perception, clinical knowledge and perioperative practice – the Frankfurt experience. Transfus Med Hemotherapy 42 (2015), 91–97.
4. Spahn, D.R., Goodnough, L.T., Alternatives to blood transfusion. Lancet 381 (2013), 1855–1865.
5. [5] Kassebaum, N.J., Jasrasaria, R., Naghavi, M., et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood 123 (2014), 615–624.
6. [6] Musallam, K.M., Tamim, H.M., Richards, T., et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet 378 (2011), 1396–1407.
7. [7] Baron, D.M., Hochrieser, H., Posch, M., et al. European surgical outcomes study group for the trials groups of the European society of intensive care M, the European society of A: preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. Br J Anaesth 113 (2014), 416–423.
8. Gombotz, H., Zacharowski, K., Spahn, D.R., Patient blood management. 2016, Thieme, Stuttgart ISBN 9783132004412.
9. [9] Fischer, D., Zacharowski, K.D., Meybohm, P., Savoring every drop – vampire or mosquito?. Crit Care, 18, 2014, 306.
10. [10] DeLoughery, T.G., Microcytic anemia. N Engl J Med 371 (2014), 1324–1331.
11. [11] McLean, E., Cogswell, M., Egli, I., et al. Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993-2005. Public Health Nutr 12 (2009), 444–454.
12. [12] Weiser, T.G., Regenbogen, S.E., Thompson, K.D., et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 372 (2008), 139–144.
13. [13] Whitlock, E.L., Kim, H., Auerbach, A.D., Harms associated with single unit perioperative transfusion: retrospective population based analysis. BMJ, 350, 2015, h3037.
14. [14] Guralnik, J.M., Eisenstaedt, R.S., Ferrucci, L., et al. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood 104 (2004), 2263–2268.
15. [15] Goodnough, L.T., Vizmeg, K., Sobecks, R., et al. Prevalence and classification of anemia in elective orthopedic surgery patients: implications for blood conservation programs. Vox Sang 63 (1992), 90–95.
16. [16] Goodnough, L.T., Schrier, S.L., Evaluation and management of anemia in the elderly. Am J Hematol 89 (2014), 88–96.
17. [17] Weiss, G., Goodnough, L.T., Anemia of chronic disease. N Engl J Med 352 (2005), 1011–1023.
18. [18] Halm, E.A., Wang, J.J., Boockvar, K., et al. The effect of perioperative anemia on clinical and functional outcomes in patients with hip fracture. J Orthop Trauma 18 (2004), 369–374.
19. [19] Litton, E., Xiao, J., Ho, K.M., Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. Bmj, 347, 2013, f4822.
20. [20] Ishida, J.H., Marafino, B.J., McCulloch, C.E., et al. Receipt of intravenous iron and clinical outcomes among hemodialysis patients hospitalized for infection. Clin J Am Soc Nephrol 10 (2015), 1799–1805.
21. [21] Heming, N., Letteron, P., Driss, F., et al. Efficacy and toxicity of intravenous iron in a mouse model of critical care anemia*. Crit Care Med 40 (2012), 2141–2148.
22. [22] Munoz, M., Gomez-Ramirez, S., Cuenca, J., et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion 54 (2014), 289–299.
23. Spahn, D.R., Zacharowski, K., Non-treatment of preoperative anaemia is substandard clinical practice. Br J Anaesth 115 (2015), 1–3.
24. [24] Hebert, P.C., Carson, J.L., Transfusion threshold of 7 g per deciliter – the new normal. N Engl J Med 371 (2014), 1459–1461.
25. [25] Murphy, G.J., Pike, K., Rogers, C.A., et al. Liberal or restrictive transfusion after cardiac surgery. N Engl J Med 372 (2015), 997–1008.
26. [26] Hollis, R.H., Singletary, B.A., McMurtrie, J.T., et al. Blood transfusion and 30-Day mortality in patients with coronary artery disease and anemia following noncardiac surgery. JAMA Surg 151:2 (2016), 139–145, 10.1001/jamasurg.2015.3420.
27. [27] Hebert, P.C., Wells, G., Blajchman, M.A., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 340 (1999), 409–417.
28. [28] Hajjar, L.A., Vincent, J.L., Galas, F.R., et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial. Jama 304 (2010), 1559–1567.
29. [29] Carson, J.L., Terrin, M.L., Noveck, H., et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 365 (2011), 2453–2462.
30. Villanueva, C., Colomo, A., Bosch, A., et al. Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 368 (2013), 11–21.
31. [31] Robertson, C.S., Hannay, H.J., Yamal, J.M., et al. Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury: a randomized clinical trial. JAMA 312 (2014), 36–47.
32. [32] Holst, L.B., Haase, N., Wetterslev, J., et al. Scandinavian Critical Care Trials G: lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med 371 (2014), 1381–1391.
33. [33] Spahn, D.R., Spahn, G.H., Stein, P., Evidence base for restrictive transfusion triggers in high-risk patients. Transfus Med Hemotherapy 42 (2015), 110–114.
34. [34] Shander, A., Hofmann, A., Ozawa, S., et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 50 (2010), 753–765.
35. [35] Gross, I., Seifert, B., Hofmann, A., et al. Patient blood management in cardiac surgery results in fewer transfusions and better outcome. Transfusion 55 (2015), 1075–1081.
36. [36] Goodnough, L.T., Shieh, L., Hadhazy, E., et al. Improved blood utilization using real-time clinical decision support. Transfusion 54 (2014), 1358–1365.
37. [37] Goodnough, L.T., Maggio, P., Hadhazy, E., et al. Restrictive blood transfusion practices are associated with improved patient outcomes. Transfusion 54 (2014), 2753–2759.
38. [38] Carson, J.L., Carless, P.A., Hebert, P.C., Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev, 4, 2012 CD002042.
39. [39] Rohde, J.M., Dimcheff, D.E., Blumberg, N., et al. Health care-associated infection after red blood cell transfusion: a systematic review and meta-analysis. JAMA 311 (2014), 1317–1326.
40. [40] Holst, L.B., Petersen, M.W., Haase, N., et al. Restrictive versus liberal transfusion strategy for red blood cell transfusion: systematic review of randomised trials with meta-analysis and trial sequential analysis. BMJ, 350, 2015, h1354.
41. [41] Mehra, T., Seifert, B., Bravo-Reiter, S., et al. Implementation of a patient blood management monitoring and feedback program significantly reduces transfusions and costs. Transfusion 55:12 (2015 Dec), 2807–2815, 10.1111/trf.13260 [Epub 2015 Aug 11].
42. [42] Spahn, D.R., Bouillon, B., Cerny, V., et al. Management of bleeding and coagulopathy following major trauma: an updated European guideline. Crit Care, 17, 2013, R76.
43. [43] Weber, C.F., Gorlinger, K., Meininger, D., et al. Point-of-Care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology 117 (2012), 531–547.
44. [44] Haas, T., Fries, D., Tanaka, K.A., et al. Usefulness of standard plasma coagulation tests in the management of perioperative coagulopathic bleeding: is there any evidence?. Br J Anaesth 114 (2015), 217–224.
45. [45] Davenport, R., Manson, J., De'Ath, H., et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 39 (2011), 2652–2658.
46. [46] Theusinger, O.M., Nurnberg, J., Asmis, L.M., et al. Rotation thromboelastometry (ROTEM) stability and reproducibility over time. Eur J Cardiothorac Surg 37 (2010), 677–683.
47. [47] Ganter, M.T., Hofer, C.K., Coagulation monitoring: current techniques and clinical use of viscoelastic point-of-care coagulation devices. Anesth Analg 106 (2008), 1366–1375.
48. [48] Hartog, C.S., Reuter, D., Loesche, W., et al. Influence of hydroxyethyl starch (HES) 130/0.4 on hemostasis as measured by viscoelastic device analysis: a systematic review. Intensive Care Med 37 (2011), 1725–1737.
49. [49] Whiting, D., DiNardo, J.A., TEG and ROTEM: technology and clinical applications. Am J Hematol 89 (2014), 228–232.
50. [50] Grottke, O., Levy, J.H., Prothrombin complex concentrates in trauma and perioperative bleeding. Anesthesiology 122 (2015), 923–931.
51. [51] Theusinger, O.M., Stein, P., Spahn, D.R., Applying ‘patient blood management’ in the trauma center. Curr Opin Anaesthesiol 27 (2014), 225–232.
52. [52] Roberts, I., Shakur, H., Afolabi, A., et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 377 (2011), 1096–1101 1101 e1–2.
53. [53] Shakur, H., Roberts, I., Bautista, R., et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 376 (2010), 23–32.
54. [54] Schochl, H., Maegele, M., Solomon, C., et al. Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med, 20, 2012, 15.
55. [55] Schochl, H., Nienaber, U., Maegele, M., et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care, 15, 2011, R83.
56. [56] Schoechl, H., Nienaber, U., Hofer, G., et al. Goal-directed coagulation management of major trauma patients using rotation thromboelastometry (ROTEM)-guided administration of fibrinogen and prothrombin complex concentrate. Crit Care, 14, 2010, R55.
57. [57] Holcomb, J.B., Tilley, B.C., Baraniuk, S., et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial. JAMA 313 (2015), 471–482.
58. [58] Khan, S., Davenport, R., Raza, I., et al. Damage control resuscitation using blood component therapy in standard doses has a limited effect on coagulopathy during trauma hemorrhage. Intensive Care Med 41 (2015), 239–247.
59. [59] Nascimento, B., Callum, J., Tien, H., et al. Effect of a fixed-ratio (1:1:1) transfusion protocol versus laboratory-results-guided transfusion in patients with severe trauma: a randomized feasibility trial. Cmaj 185 (2013), E583–E589.
60. [60] Nardi, G., Agostini, V., Rondinelli, B., et al. Trauma-induced coagulopathy: impact of the early coagulation support protocol on blood product consumption, mortality and costs. Crit Care, 19, 2015, 83.
61. [61] Gorlinger, K., Dirkmann, D., Hanke, A.A., et al. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study. Anesthesiology 115 (2011), 1179–1191.
62. [62] Ranucci, M., Baryshnikova, E., Crapelli, G.B., et al. Surgical Clinical Outcome RG: randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. J Am Heart Assoc, 2015, 4.
63. [63] Pearse, B.L., Smith, I., Faulke, D., et al. Protocol guided bleeding management improves cardiac surgery patient outcomes. Vox Sang 109 (2015), 267–279.
64. [64] Koch, C.G., Reineks, E.Z., Tang, A.S., et al. Contemporary bloodletting in cardiac surgical care. Ann Thorac Surg 99 (2015), 779–784.
65. [65] Vincent, J.L., Baron, J.F., Reinhart, K., et al. Anemia and blood transfusion in critically ill patients. JAMA 288 (2002), 1499–1507.
66. [66] Widness, J.A., Madan, A., Grindeanu, L.A., et al. Reduction in red blood cell transfusions among preterm infants: results of a randomized trial with an in-line blood gas and chemistry monitor. Pediatrics 115 (2005), 1299–1306.
67. [67] O'Grady, N.P., Barie, P.S., Bartlett, J.G., et al. American college of critical care M, infectious diseases society of A: guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American college of critical care medicine and the infectious diseases society of America. Crit Care Med 36 (2008), 1330–1349.
68. [68] Smoller, B.R., Kruskall, M.S., Horowitz, G.L., Reducing adult phlebotomy blood loss with the use of pediatric-sized blood collection tubes. Am J Clin Pathol 91 (1989), 701–703.
69. [69] Mukhopadhyay, A., Yip, H.S., Prabhuswamy, D., et al. The use of a blood conservation device to reduce red blood cell transfusion requirements: a before and after study. Crit Care, 14, 2010, R7.
70. [70] Lier, H., Krep, H., Schroeder, S., et al. Preconditions of hemostasis in trauma: a review. The influence of acidosis, hypocalcemia, anemia, and hypothermia on functional hemostasis in trauma. J Trauma 65 (2008), 951–960.
71. [71] Watts, D.D., Trask, A., Soeken, K., et al. Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma 44 (1998), 846–854.
72. [72] Low, L.L., Harrington, G.R., Stoltzfus, D.P., The effect of arterial lines on blood-drawing practices and costs in intensive care units. Chest 108 (1995), 216–219.
73. [73] Frasca, D., Dahyot-Fizelier, C., Catherine, K., et al. Accuracy of a continuous noninvasive hemoglobin monitor in intensive care unit patients. Crit Care Med 39 (2011), 2277–2282.
74. [74] O'Reilly, M., Understanding noninvasive and continuous hemoglobin monitoring. Crit Care Med, 41, 2013, e52.
75. [75] Coquin, J., Dewitte, A., Manach, Y.L., et al. Precision of noninvasive hemoglobin-level measurement by pulse co-oximetry in patients admitted to intensive care units for severe gastrointestinal bleeds. Crit Care Med 40 (2012), 2576–2582.
76. [76] Bagshaw, S.M., Laupland, K.B., Boiteau, P.J., et al. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system. J Crit Care 20 (2005), 155–161.
77. [77] Monchi, M., Berghmans, D., Ledoux, D., et al. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 30 (2004), 260–265.
78. [78] Wu, M.Y., Hsu, Y.H., Bai, C.H., et al. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis 59 (2012), 810–818.
79. [79] Shantikumar, S., Patel, S., Handa, A., The role of cell salvage autotransfusion in abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 42 (2011), 577–584.
80. [80] Carless, P.A., Henry, D.A., Moxey, A.J., et al. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev, 17(3), 2010 Mar, 10.1002/14651858.CD001888.pub3 CD001888.